Literature DB >> 2321579

Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer.

S Toikkanen1, H Joensuu, P Klemi.   

Abstract

One hundred fifteen patients with postsurgical stage T1-2N0 breast cancer with the minimum follow-up of 22 years and from a defined population were studied to find reliable prognostic factors predicting long-term survival rate. The 30-year survival rate corrected for intercurrent deaths was 75%, and no deaths of breast cancer occurred after the nineteenth year of follow-up. The 30-year crude survival rate was only 28%, indicating that the great majority of these patients ultimately die of other causes than breast cancer. The nuclear DNA content could be determined by flow cytometry in 95 of the 115 cases, and 52 (55%) of them were nondiploid. DNA ploidy (diploid vs. nondiploid, P = 0.11) did not have a significant influence on long-term survival rate, but cancers with the DNA index less than 1.2 had more favorable prognosis in a univariate analysis than those with the DNA index more than 1.2 (P = 0.02). The most important independent prognostic factor in Cox's multivariate analysis was the presence of lymphatic vessel invasion of cancer cells (P less than 0.001). Several other factors, including histologic grade and type, extent of necrosis, type of tumor margin, age at diagnosis, and primary tumor size could be shown to be of prognostic value in univariate and/or multivariate analyses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321579     DOI: 10.1093/ajcp/93.4.471

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma.

Authors:  B Uzarević; M Petrovecki; M Marusić; J Jakić-Razumović; Z Hutinec; A Sabioncello; S Gamulin
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

2.  Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.

Authors:  A E Pinto; S André; M Nogueira; E Mendonça; J Soares
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

3.  Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.

Authors:  D Nikolić-Vukosavljević; M Markićević; G Grujić-Adanja; A Petrović; K Kanjer; Z Nesković-Konstantinović
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.

Authors:  D W Hedley; G M Clark; C J Cornelisse; D Killander; T Kute; D Merkel
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

5.  Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.

Authors:  P S Hupperets; B Schutte; C van Assche; L J Schouten; J Jager; J de Jong; G H Blijham
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.